John Vandermosten

Stock Analyst at Zacks Investment Research

(0.03)
# 4,624
Out of 5,036 analysts
1
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by John Vandermosten

Tiziana Life Sciences
Apr 12, 2021
Initiates: Not Rated
Price Target: $7.5
Current: $1.96
Upside: +282.65%